Time and Location:
24 – 25 May 2023 | London, UK
Meet us in London, engage with our speaker face to face about China GVP and relevant regulation changes and get real-time feedback for your questions.
INTRODUCTION
Pharmacovigilance regulations in China are constantly evolving and rapidly changing. With China becoming increasingly important for pharmaceutical companies, it is essential to remain updated on the latest regulatory developments to ensure compliance and safety.
As a leading global conference and exhibition on pharmacovigilance, Accestra is proud to sponsor and present about China GVP at the 9th Annual International Conference and Exhibition on Pharmacovigilance, Regulatory Affairs, Risk Management, and Clinical Trials.
2023 May 25, 14:00 – 14:30 PM (UK time)
2023 May 25, 14:00 – 14:30 PM (UK time)
- Overview of China PV framework
- Updates on China’s GVP policies
- China’s GVP requirements
- Best practices for compliance with China’s GVP requirements and authority inspections
- Tips and pitfalls
- Q&A
SPEAKER:
Marylene Zhan, Senior consultant at Accestra Consulting
Marylene.zhan@accestra.com
Ms. Marylene Zhan is a senior consultant at Accestra Consulting with extensive experience in pharmacovigilance and regulatory affairs. With a Master’s Degree from the Zhongnan University of Economics and Law. Marylene is a seasoned bilingual and bicultural consultant who specializes in China regulatory compliance and pharmacovigilance services (RA/PV). She has a wealth of knowledge on Chinese Pharmaceutical regulations and in-depth insight into dealing with Chinese market access requirements. Marylene has a rich experience in serving international pharma companies with market entry into China, providing support in the areas of adverse event monitoring and reporting, literature screening, PV agreements, Chinese GVP and local regulations, SOP & PSMF writing, and more.
